Chemicals · Specialty Chemicals
Specialty Chemicals Sector Primer
A 40-page primer plus Excel valuation model on specialty chemical companies: pass-through, margin stability, ROIC against WACC and a ten-year DCF.
2026 Edition · data as of June 2026
- pages
- 40
- sections
- 15
- model sheets
- 12
Choose a format
PDF only
The full primer
£25 / ~$32
- 40 pages, 15 sections
- Worked examples and applied cases
- 2026 Edition, data as of June 2026
Excel model
Valuation template
£45 / ~$58
- 12 sheets (.xlsx)
- Runs the primer's worked valuations live
PDF + Excel model Best value
Both files together
£59 / ~$76
- The 40-page primer
- The 12-sheet Excel model
- £70 bought separately · £11 less
Complete Chemicals Library
All three Chemicals industries: three primers, three Excel models (Commodity Chemicals, Specialty Chemicals, and Industrial Gases).
Inside the primer
The 15-section contents, a worked valuation page, and the Excel dashboard.
Contents
- 01 How Specialty Chemicals Make Money
- 02 Listed Company Types
- 03 From Pricing Power to Commodity-Linked
- 04 Segments and Sub-Markets
- 05 Revenue Drivers: Framework
- 06 Cost Structure: Pass-Through and Margins
- 07 Valuation Frameworks
- 08 Worked Example: Pricing-Power Coatings Company
- 09 Worked Example: Commodity-Linked Specialty
- 10 Applied Cases: Bridges and Segment Economics
- 11 Applied Cases: Portfolio, Leverage and Cycle
- 12 The Companies in This Primer
- 13 Key Metrics and Screening
- 14 Risks, Benchmarks and Case Study
- 15 Glossary and Cheat Sheet
Worked examples and applied cases · 40 pages · 15 sections · 2 worked archetypes
The Excel model
Educational material for professional use. This primer and its model are not investment advice or a recommendation to buy or sell any security, and they are not personalised. Worked valuations use illustrative calibrations, not fair-value estimates for any company.
Specialty chemical companies are paid for what a product does, such as corrosion protection or infection control, rather than for the molecule inside it. Because the input is a small share of the customer's cost and switching is expensive, a true specialty business can pass raw-material inflation through and hold its margin. The label alone proves nothing, though: the filed price bridge, the stability of gross margin and returns above the cost of capital are what show whether a company earns specialty economics or is a commodity business under another name.
Specialty chemicals valuation benchmarks by business model
The multiple follows the business model, and a similar EBITDA margin can hide very different earnings quality. The margin ranges below come from the six companies the primer profiles; the anchors are its cross-checks.
| Business model | Gross / EBITDA margin | Valuation anchor | What sets the position |
|---|---|---|---|
| Coatings | 41-49% / 17-20% | Stable-margin DCF; about 13.5x EV/EBITDA as a cross-check | Filed price contribution; gross margin within 100 basis points a year |
| Service and formulation | 44-45% / 23-24% | Stable-margin DCF; the same specialty cross-check | Pass-through visible in the price bridge |
| Specialty materials | 34-36% / 19-24% | DCF segment by segment | Segment mix; portfolio changes distort one group multiple |
| Commodity-linked specialty | 10-15% / 18-22% (adjusted) | Price-reversion DCF; about 8.5x basic-chemicals multiple as a cross-check only | The output price; gross margin moves of more than 200 basis points |
The primer builds its discount rates at 7.66% for a coatings company and 8.94% for a higher-beta lithium producer. A company moves up the range when its return on invested capital clears that rate by more than 3 points, and down when the spread turns negative. Damodaran's January 2026 aggregates show why the premium exists at all: US specialty chemicals earn 3.70 points above their cost of capital and basic chemicals 2.50 points below, and the EV/EBITDA multiples sit at 13.4x against 8.6x.
Worked example: a specialty chemicals DCF
Take a hypothetical coatings company with $4.0B of revenue, an 18% EBITDA margin and 3.5% organic growth a year, 2.5% after year 10. It earns 16.1% on $2,800M of invested capital, so each year it reinvests 3.5% divided by 16.1%, about 22%, of after-tax operating profit to fund growth. Cash flows are discounted at 7.66%.
| Step | Amount |
|---|---|
| PV of free cash flow, years 1-10 | $2,852M |
| Plus PV of terminal value (2.5% growth, still paid for) | +$5,091M |
| Enterprise value | $7,943M |
| Less net debt | -$1,400M |
| Equity value | $6,543M |
| Value per share (100M shares) | $65.43 |
That is 11.0 times this year's $720M of EBITDA. The 13.5x market cross-check gives $83.20 a share, because a published multiple carries the market's own growth and return assumptions, more generous than this company's inputs. The DCF shows which input would have to change to close the gap.
Now keep everything the same except the return on new capital, and cut it to the 7.66% cost of capital. Reinvestment rises to almost half of profit, growth adds no value, and the company is worth $46.41 a share, 8.4 times EBITDA. A coatings label on a business that only earns its cost of capital is worth about a basic-chemicals multiple.
The primer shows the year-by-year schedule, a raw-material shock run through pass-through, a sensitivity grid across margin and terminal growth, and a lithium producer valued with the same method. The Excel model does the same with your own inputs.
Which specialty chemicals valuation method fits which company
| Company type | Primary method | Check with | Why |
|---|---|---|---|
| Coatings | Stable-margin DCF | Specialty EV/EBITDA market multiple | Stable EBITDA and a filed price contribution |
| Service and formulation | Stable-margin DCF plus bridge quality | Gross margin stability | The service mix supports pass-through |
| Specialty materials | DCF by segment | Segment organic growth | Portfolio changes distort a single multiple |
| Commodity-linked specialty | Price-reversion DCF | Basic-chemicals multiple, as a cross-check only | The cycle resets EBITDA and gross margin together |
What the full primer adds
The primer builds the tools in order: how specialty chemicals make money, the listed company types, where businesses sit between pricing power and the commodity cycle, then revenue drivers and the cost side of pass-through and margins. Two worked chapters value hypothetical companies with the same method: a coatings company with pricing power on a ten-year DCF, and a lithium producer whose price recovers from below its cash cost. Applied cases on price bridges, segment economics, portfolio change, leverage and the cycle follow, and screening closes with margin stability and the return on capital against its cost.
Free guides on the site cover the individual pieces: specialty against commodity chemicals, pricing power and pass-through, ROIC in specialty chemicals, paint and coatings economics, gross margins by company, lithium carbonate against hydroxide and valuing specialty chemicals. Research profiles for Sherwin-Williams, Ecolab, PPG Industries, DuPont, IFF and Albemarle apply the same method to filed results. The companion Excel model spans twelve sheets: the coatings and commodity-linked engines, a valuation summary, a pass-through test, a multiple derived from ROIC, growth and WACC, return and leverage screens and a live sensitivity grid.
Sheets: Quick Start, Instructions, Assumptions, Specialty Coatings, Commodity-Linked, Valuation Summary, Pass-Through Test, Multiple Premium, ROIC vs WACC, Leverage Screen, Sensitivity, Dashboard.
Specialty chemicals valuation: free guides
Specialty chemicals valuation FAQ
- How do you value a specialty chemicals company?
- Test the label first: a positive price contribution in the filed growth bridge, gross margin that moves less than 100 basis points a year, and returns above the cost of capital. A company that passes gets a ten-year DCF with a stable margin, where every dollar of growth is paid for by reinvesting growth divided by ROIC. One that fails gets a DCF driven by its output price. A market EV/EBITDA multiple is a cross-check in both cases.
- What EV/EBITDA multiple do specialty chemical companies trade on?
- Damodaran's January 2026 industry aggregates put US specialty chemicals at 13.4x EV/EBITDA against 8.6x for basic chemicals, a premium of about 56%. The primer uses 13.5x and 8.5x as round cross-checks and a forward P/E band of 18-24x on normalised earnings. These are sector totals and drift with the market, so refresh them before use.
- What makes a chemical company specialty rather than commodity?
- Its economics. A specialty business sells what the product does, the input is a small share of the customer's cost, and switching is expensive, so raw-material inflation passes through and gross margin holds. When volume rises while sales fall, or gross margin swings by more than 200 basis points in a year, the output price is driving earnings and the business should be valued like a commodity producer.
- What discount rate is used for a specialty chemicals DCF?
- The primer builds it: a 4.50% illustrative Treasury yield plus beta times a 4.23% equity risk premium, blended with 6.00% debt after 25% tax. That gives 7.66% for its coatings company (beta 0.97, 23% debt) and 8.94% for its lithium producer (beta 1.40, 25% debt). Damodaran's sector costs of capital, 7.25% for specialty and 6.22% for basic, show that the premium does not come from cheaper funding.
- Why do specialty chemicals trade at a premium to commodity chemicals?
- Because their returns clear the cost of capital and commodity producers' returns do not. On Damodaran's January 2026 aggregates, specialty chemicals earn 10.95% on capital against a 7.25% cost, a spread of 3.70 points, while basic chemicals earn 3.72% against 6.22%. The primer reads a spread above 3 points as support for a premium, 0-3 points as fair and below zero as grounds to de-rate.
See this methodology applied to a real company:
Sherwin-Williams (SHW) →